ArticleInternational journal of molecular sciences2023

Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients.

Sawsan Elgohary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.